Business Context and Reporting Period
This Form 6-K filing is submitted by Hexindai Inc., a foreign private issuer, for the month of October 2018. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing was signed by Zhang Qisen (Johnson), Chief Financial Officer, on October 15, 2018. Note: The input metadata references "Akso Health Group," but the filing text explicitly identifies the registrant as Hexindai Inc.
Key Financial Metrics
The filing text provided does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The document does not provide comparative financial data or describe material changes versus prior periods. The filing serves primarily as a cover sheet for an attached press release (Exhibit 99.1), the content of which is not included in the provided text.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, risk factors, contingencies, or descriptions of unusual items. These details would likely be contained within the referenced Exhibit 99.1 Press Release, which is not part of the input content.
Investor Verification Checklist
- Verify the correct registrant name: The filing is for Hexindai Inc., not Akso Health Group.
- Locate and review Exhibit 99.1 (Press Release) to obtain the actual financial results or material event details.
- Confirm the specific date of the press release referenced in the exhibit index.